BioRestorative Therapies Regains Compliance with Nasdaq Listing Rule 5250(c)(1); Reports First Quarter 2024 Financial Results
June 17, 2024 07:05 ET
|
BioRestorative Therapies, Inc
- Significant YoY improvement in operating performance - - Ends Q1-2024 with $16.4 million cash, cash equivalents, and marketable securities - MELVILLE, N.Y., June 17, 2024 (GLOBE NEWSWIRE) --...
SAGALIAM ACQUISITION CORP. REGAINS COMPLIANCE WITH NASDAQ LISTING RULE 5250(C)(1)
June 02, 2023 13:50 ET
|
Sagaliam Acquisition Corp
New York, NY, June 02, 2023 (GLOBE NEWSWIRE) -- Sagaliam Acquisition Corp. (NASDAQ: “SAGAU”, “SAGA”, “SAGAR”) (“we”, “us”, “our”, or the “Company”) announced today that it received notice from...
Mercurity Fintech Holding Inc. Regains Compliance with Nasdaq Listing Rule 5250(c)(1)
June 24, 2022 17:00 ET
|
Mercurity Fintech Holding Inc.
SHENZHEN, China, June 24, 2022 (GLOBE NEWSWIRE) -- Mercurity Fintech Holding Inc. (the "Company" or "MFH") (Nasdaq: MFH), a digital fintech group powered by blockchain technology, today announced...
Akers Biosciences Receives Notice of Delinquent Form 10-Q Filing from Nasdaq
May 25, 2018 16:30 ET
|
Akers Biosciences Inc
THOROFARE, N.J., May 25, 2018 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health information technologies, announces...